Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients

Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients

Abstract Despite experimental evidence of beneficial metabolic, antiatherosclerotic and antiinflammatory effects of the 30 kDa adipokine, adiponectin, maintenance hemodialysis (MHD) patients with high adiponectin blood levels have paradoxically high mortality rates. We aimed to examine the direction...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ilia Beberashvili, Tamar Cohen-Cesla, Amin Khatib, Ramzia Abu Hamad, Ada Azar, Kobi Stav, Shai Efrati
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/7dff09d1b1f44266b640229fb4757fe7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares